Ditchcarbon
  • Contact
  1. Organizations
  2. Ergomed
Public Profile
Research Services
GB
updated 22 days ago

Ergomed Sustainability Profile

Company website

Ergomed plc, a leading provider of specialised services to the pharmaceutical industry, is headquartered in Great Britain. Founded in 1997, the company has established a strong presence in key operational regions, including Europe and North America. Ergomed focuses on two main business areas: drug development and post-marketing services, offering a unique blend of expertise that enhances the efficiency of clinical trials. With a commitment to quality and innovation, Ergomed provides a range of core services, including clinical research, pharmacovigilance, and regulatory affairs. The company has achieved notable milestones, such as its successful listing on the London Stock Exchange, solidifying its position as a trusted partner in the life sciences sector. Ergomed's dedication to tailored solutions and client satisfaction sets it apart in a competitive market.

DitchCarbon Score

How does Ergomed's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

32

Industry Average

Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

26

Industry Benchmark

Ergomed's score of 32 is higher than 59% of the industry. This can give you a sense of how well the company is doing compared to its peers.

59%

Let us know if this data was useful to you

Ergomed's reported carbon emissions

In 2022, Ergomed reported total carbon emissions of approximately 46,150 kg CO2e, with emissions distributed across various scopes. Specifically, Scope 1 emissions were about 730 kg CO2e, primarily from stationary combustion. Scope 2 emissions, related to purchased electricity, accounted for approximately 14,290 kg CO2e. The most significant contributions came from Scope 3 emissions, which totalled around 34,270 kg CO2e, with business travel contributing about 17,290 kg CO2e and upstream transportation and distribution adding approximately 18,980 kg CO2e. Comparatively, in 2021, Ergomed's total emissions were about 60,640 kg CO2e, indicating a reduction of approximately 14,490 kg CO2e year-on-year. This reduction reflects a commitment to improving sustainability practices, although no specific reduction targets or initiatives have been documented. Ergomed's emissions data is sourced from Ergomed Group Limited, with no cascading from a parent company. The company has not set any Science-Based Targets Initiative (SBTi) reduction targets or made specific climate pledges, indicating a potential area for future commitment in climate action. Overall, Ergomed's emissions profile highlights the importance of addressing Scope 3 emissions, which represent a significant portion of their carbon footprint.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20212022
Scope 1
60
000
Scope 2
25,450
00,000
Scope 3
43,740
00,000

How Carbon Intensive is Ergomed's Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Ergomed's primary industry is Research and development services (73), which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Ergomed's Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Ergomed is in GB, which has a very low grid carbon intensity relative to other regions.

Ergomed's Scope 3 Categories Breakdown

Ergomed's Scope 3 emissions, which decreased by 17% last year and decreased by approximately 17% since 2021, demonstrating supply chain emissions tracking. Most of their carbon footprint comes from suppliers and value chain emissions, with Scope 3 emissions accounting for 71% of total emissions under the GHG Protocol, with "Upstream Transportation & Distribution" being the largest emissions source at 52% of Scope 3 emissions.

Top Scope 3 Categories

2022
Upstream Transportation & Distribution
52%
Business Travel
48%

Ergomed's Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Ergomed has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Ergomed's Emissions with Industry Peers

Medpace Holdings, Inc.

US
•
Research and development services (73)
Updated 12 days ago

Icon

IE
•
Research and development services (73)
Updated 10 days ago

Syneos Health, LLC

US
•
Research and development services (73)
Updated 9 days ago

Parexel

US
•
Research and development services (73)
Updated 21 days ago

Konecranes

FI
•
Machinery and equipment n.e.c. (29)
Updated 10 days ago

Syneos Health US, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 19 days ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251031.3
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy